We are live on ! Find out more
SURF

Surface Oncology, Inc. Common Stock
SURF

Delisted

SURF was delisted on the 7th of September, 2023.

Back to rankings

91 hedge funds and large institutions have $213M invested in Surface Oncology, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 10

54% more funds holding

Funds holding: 59 → 91 (+32)

44% more capital invested

Capital invested by funds: $149M → $213M (+$64.8M)

33% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 18

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

41% less call options, than puts

Call options by funds: $1.3M | Put options by funds: $2.2M

Holders
91
Holders Change
+32
Holders Change %
+54.24%
% of All Funds
1.61%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
42
Increased
24
Reduced
18
Closed
10
Calls
$1.3M
Puts
$2.2M
Net Calls
-$895K
Net Calls Change
-$1.03M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$18.2M
2
FCM
Farallon Capital Management
California
+$8.69M
3
Morgan Stanley
Morgan Stanley
New York
+$8.57M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.97M
5
BlackRock
BlackRock
New York
+$5.75M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$28.5M
2
VA
VR Adviser
New York
-$21.2M
3
AVAI
Atlas Venture Associates IX
Massachusetts
-$14.8M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$12.1M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$1.56M +$740K +85,190 +102%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$1.44M +$221K +25,416 +19%
HF
28
HRT Financial
New York
$1.36M +$1.28M +147,140 New
SCM
29
Silverarc Capital Management
Massachusetts
$1.2M +$1.13M +130,000 New
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$1.12M +$250K +28,812 +31%
Man Group
31
Man Group
United Kingdom
$1.11M +$770K +88,624 +280%
AG
32
Artal Group
Luxembourg
$924K +$869K +100,000 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$699K +$46.3K +5,329 +8%
CSS
34
Cubist Systematic Strategies
Connecticut
$604K +$524K +60,311 +1,193%
SSA
35
Schonfeld Strategic Advisors
New York
$585K -$338K -38,832 -38%
Citadel Advisors
36
Citadel Advisors
Florida
$539K +$507K +58,375 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$459K +$432K +49,679 New
EC
38
EcoR1 Capital
California
$449K -$28.5M -3,284,619 -99%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$445K -$8.69K -1,000 -2%
Two Sigma Investments
40
Two Sigma Investments
New York
$441K -$1.87M -214,593 -82%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$392K +$351K +40,413 +2,060%
RJA
42
Raymond James & Associates
Florida
$388K -$400K -46,002 -52%
Stifel Financial
43
Stifel Financial
Missouri
$373K +$155K +17,800 +79%
Northern Trust
44
Northern Trust
Illinois
$352K -$7.01K -807 -2%
6CM
45
683 Capital Management
New York
$346K +$325K +37,433 New
Capstone Investment Advisors
46
Capstone Investment Advisors
New York
$332K +$313K +35,967 New
Wells Fargo
47
Wells Fargo
California
$318K +$299K +34,449 +26,499%
Vontobel Holding
48
Vontobel Holding
Switzerland
$277K +$261K +30,014 New
Janney Montgomery Scott
49
Janney Montgomery Scott
Pennsylvania
$275K +$156K +17,908 +152%
QSS
50
Quantitative Systematic Strategies
Florida
$260K +$40.3K +4,633 +20%
1
2
3 4 5

SURF Hedge Fund Activity: Q4 2020 in Review

91 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q4 2020, worth a combined $213M — up 44% from $149M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new SURF positions and 10 closed out — a net gain of 32 holders — while 24 added to existing stakes and 18 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $18.2M. The largest seller was EcoR1 Capital, cutting an estimated $28.5M.

  • 91 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q4 2020, up from 59 in Q3 2020.
  • Funds reported $213M of Surface Oncology, Inc. Common Stock stock for Q4 2020, up 44% quarter-over-quarter.
  • 42 funds opened new Surface Oncology, Inc. Common Stock positions in Q4 2020 and 10 closed out, a net change of +32 holders.
  • The largest Surface Oncology, Inc. Common Stock buyer in Q4 2020 was ARK Investment Management, an estimated $18.2M added.
  • The largest Surface Oncology, Inc. Common Stock seller in Q4 2020 was EcoR1 Capital, an estimated $28.5M sold.

Based on aggregated 13F filings for Q4 2020.